Li Ling Tan

Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society

Alexander R. Lyon, Susan Dent, Susannah Stanway et al. · European Journal of Heart Failure · 2020 · 770 citations · Full text

Medicine, Cardiology, Oncology +16

Activity and Outcomes of a Cardio-Oncology Service in the United Kingdom—A Five-Year Experience

Nilesh Pareek, Joaquim Cevallos, Pedro Moliner et al. · European Journal of Heart Failure · 2018 · 142 citations

Medicine, Cardiology, Oncology +8

Neutrophil-to-Lymphocyte Ratio Predicts Development of Immune-Related Adverse Events and Outcomes from Immune Checkpoint Blockade: A Case-Control Study

Pei Yi Lee, Kellynn Oen, Grace Rui Si Lim et al. · Cancers · 2021 · 77 citations · Full text

Life Sciences, Immunology, Oncology +17

Superior Performance of N-Terminal Pro Brain Natriuretic Peptide for Diagnosis of Acute Decompensated Heart Failure in an Asian Compared with a Western Setting

Irwani Ibrahim, Win Sen Kuan, Chris Frampton et al. · European Journal of Heart Failure · 2016 · 38 citations · Full text

Medicine, Cardiology, Internal Medicine +4

The Large Molecular Weight Polysaccharide from Wild Cordyceps and Its Antitumor Activity on H22 Tumor-Bearing Mice

Li Ling Tan, Sijing Liu, Xiaoxing Li et al. · Molecules · 2023 · 28 citations · Full text

Medicine, Oncology, Pharmacology +16